BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9930747)

  • 1. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease.
    Nourooz-Zadeh J; Liu EH; Yhlen B; Anggård EE; Halliwell B
    J Neurochem; 1999 Feb; 72(2):734-40. PubMed ID: 9930747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA).
    Nourooz-Zadeh J; Liu EH; Anggård E; Halliwell B
    Biochem Biophys Res Commun; 1998 Jan; 242(2):338-44. PubMed ID: 9446796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay.
    Musiek ES; Cha JK; Yin H; Zackert WE; Terry ES; Porter NA; Montine TJ; Morrow JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):95-102. PubMed ID: 14659440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
    Yen HC; Wei HJ; Lin CL
    Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid.
    Song WL; Lawson JA; Reilly D; Rokach J; Chang CT; Giasson B; FitzGerald GA
    J Biol Chem; 2008 Jan; 283(1):6-16. PubMed ID: 17921521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of oxidized lipid products of marine fish under acute oxidative stress.
    Chung ML; Lee KY; Lee CY
    Food Chem Toxicol; 2013 Mar; 53():205-13. PubMed ID: 23220612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo.
    Yin H; Musiek ES; Gao L; Porter NA; Morrow JD
    J Biol Chem; 2005 Jul; 280(28):26600-11. PubMed ID: 15894799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.
    Roberts LJ; Montine TJ; Markesbery WR; Tapper AR; Hardy P; Chemtob S; Dettbarn WD; Morrow JD
    J Biol Chem; 1998 May; 273(22):13605-12. PubMed ID: 9593698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.
    Leung KS; Galano JM; Durand T; Lee JC
    Free Radic Res; 2015; 49(7):816-26. PubMed ID: 25184341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
    Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of monoepoxides of arachidonic, eicosapentaenoic, and docosahexaenoic acids].
    Kuklev DV; Rybin VG; Imbs AB; Bezuglov VV
    Bioorg Khim; 1993 Nov; 19(11):1122-7. PubMed ID: 8285925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.
    Roberts LJ; Fessel JP
    Chem Phys Lipids; 2004 Mar; 128(1-2):173-86. PubMed ID: 15037162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids.
    Vigor C; Bertrand-Michel J; Pinot E; Oger C; Vercauteren J; Le Faouder P; Galano JM; Lee JC; Durand T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():65-78. PubMed ID: 24856297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation.
    Milne GL; Musiek ES; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):210-20. PubMed ID: 15650409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid.
    Gao L; Yin H; Milne GL; Porter NA; Morrow JD
    J Biol Chem; 2006 May; 281(20):14092-9. PubMed ID: 16569632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic-acid-derived isoprostanes: synthesis and discovery of two major isoprostanes.
    Chang CT; Patel P; Kang N; Lawson JA; Song WL; Powell WS; FitzGerald GA; Rokach J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5523-7. PubMed ID: 18804370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes.
    Longmire AW; Swift LL; Roberts LJ; Awad JA; Burk RF; Morrow JD
    Biochem Pharmacol; 1994 Mar; 47(7):1173-7. PubMed ID: 8161346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F2-isoprostanes and F4-neuroprostanes as markers of intracranial aneurysm development.
    Syta-Krzyżanowska A; Jarocka-Karpowicz I; Kochanowicz J; Turek G; Rutkowski R; Gorbacz K; Mariak Z; Skrzydlewska E
    Adv Clin Exp Med; 2018 May; 27(5):673-680. PubMed ID: 29790685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
    Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential applications of lipid peroxidation products - F
    De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
    Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.